AbbVie Provides Update on VENCLEXTA®/VENCLYXTO® (venetoclax) Multiple Myeloma Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. AWK
6. GNK
7. USO
8. ARGX
9. MU
10. RKLB

Go back to AbbVie Provides Update on VENCLEXTA®/VENCLYXTO® (venetoclax) Multiple Myeloma Program
AbbVie (NYSE: ABBV) Delayed: 250.33 +0.87 (0.35%)
Previous Close $249.46    52 Week High $68.12 
Open $249.49    52 Week Low $50.71 
Day High $251.49    P/E 54.30 
Day Low $248.31    EPS $4.61 
Volume 4,648,677